NVCR – novocure limited - ordinary shares (US:NASDAQ)
Novocure to Report First Quarter 2025 Financial Results
NovoCure Limited (NASDAQ: NVCR) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
NovoCure Limited (NASDAQ: NVCR) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Novocure to Participate in Leerink Partners 2025 Global Healthcare Conference
NovoCure Limited (NASDAQ: NVCR) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com